Methods and compositions associated with the granulocyte colony-stimulating factor receptor
Номер патента: EP2780322A1
Опубликовано: 24-09-2014
Автор(ы): Andrew R. Hudson, Bijan Pedram, C. Arjan VAN OEVEREN, Jason C. Pickens, Keith MARSCHKE, Lin Zhi, Lino J. Valdez, Steven L. Roach, Virginia H. GRANT, Yixing Shen
Принадлежит: Ligand Pharmaceuticals Inc
Опубликовано: 24-09-2014
Автор(ы): Andrew R. Hudson, Bijan Pedram, C. Arjan VAN OEVEREN, Jason C. Pickens, Keith MARSCHKE, Lin Zhi, Lino J. Valdez, Steven L. Roach, Virginia H. GRANT, Yixing Shen
Принадлежит: Ligand Pharmaceuticals Inc
Реферат: Some embodiments include compositions and methods of using or identifying compounds that modulate the activity of the granulocyte colony-stimulating factor receptor (GCFR). Some embodiments include use of compounds to treat certain disorders, such as hematopoietic or neurological disorders.
Methods and compositions associated with the granulocyte colony-stimulating factor receptor
Номер патента: US11413274B2. Автор: Lin Zhi,Jason C. Pickens,Yixing Shen,Andrew R. Hudson,Steven L. Roach,Bijan Pedram,Lino J. Valdez,Cornelis Arjan Van Oeveren,Virginia H. GRANT,Keith MARSCHKE. Владелец: Ligand Pharmaceuticals Inc. Дата публикации: 2022-08-16.